88 related articles for article (PubMed ID: 3489207)
1. Increased concentrations of uric acid in the spinal cord of rats with chronic relapsing experimental allergic encephalomyelitis.
Honegger CG; Krenger W; Langemann H
Neurosci Lett; 1986 Aug; 69(1):109-14. PubMed ID: 3489207
[TBL] [Abstract][Full Text] [Related]
2. Changes in amino acid contents in the spinal cord and brainstem of rats with experimental autoimmune encephalomyelitis.
Honegger CG; Krenger W; Langemann H
J Neurochem; 1989 Aug; 53(2):423-7. PubMed ID: 2787389
[TBL] [Abstract][Full Text] [Related]
3. Monoamines and related substances in brainstem and spinal cord of Lewis rats during the attack and recovery of experimental autoimmune encephalomyelitis.
Krenger W; Kabiersch A; Honegger CG
Brain Res; 1989 Jul; 491(2):374-8. PubMed ID: 2475212
[TBL] [Abstract][Full Text] [Related]
4. Ganglioside spinal cord changes in chronic relapsing experimental allergic encephalomyelitis induced in the Lewis rats.
Zaprianova E; Deleva D; Hauttecoeur B; Bakalska M; Filchev A
Neurochem Res; 1997 Feb; 22(2):175-9. PubMed ID: 9016843
[TBL] [Abstract][Full Text] [Related]
5. Blood-brain and blood-spinal cord barrier permeability during the course of experimental allergic encephalomyelitis in the rat.
Juhler M; Barry DI; Offner H; Konat G; Klinken L; Paulson OB
Brain Res; 1984 Jun; 302(2):347-55. PubMed ID: 6610460
[TBL] [Abstract][Full Text] [Related]
6. Changes in the effectiveness of the blood-brain and blood-spinal cord barriers in experimental allergic encephalomyelitis.
Daniel PM; Lam DK; Pratt OE
J Neurol Sci; 1981; 52(2-3):211-9. PubMed ID: 6796652
[TBL] [Abstract][Full Text] [Related]
7. Changes of neurotransmitter systems in chronic relapsing experimental allergic encephalomyelitis in rat brain and spinal cord.
Krenger W; Honegger CG; Feurer C; Cammisuli S
J Neurochem; 1986 Oct; 47(4):1247-54. PubMed ID: 2427658
[TBL] [Abstract][Full Text] [Related]
8. Measurement of free radical scavengers in the spinal cord of rats with experimental autoimmune encephalomyelitis.
Honegger CG; Krenger W; Langemann H
Neurosci Lett; 1989 Apr; 98(3):327-32. PubMed ID: 2786169
[TBL] [Abstract][Full Text] [Related]
9. The relationship between aquaporin-4 expression and blood-brain and spinal cord barrier permeability following experimental autoimmune encephalomyelitis in the rat.
Huang XN; Wang WZ; Fu J; Wang HB
Anat Rec (Hoboken); 2011 Jan; 294(1):46-54. PubMed ID: 21157915
[TBL] [Abstract][Full Text] [Related]
10. [Asparginase in experimental allergic encephalomyelitis. VI. Asparginase in the brain and spinal cord of the rat in experimental allergic encephalomyelitis].
Valovicová E; Turský T
Biologia (Bratisl); 1967; 22(2):114-7. PubMed ID: 6047253
[No Abstract] [Full Text] [Related]
11. Chronic permeability of the central nervous system to mononuclear cells in experimental allergic encephalomyelitis in the Lewis rat.
Stohl W; Gonatas NK
J Immunol; 1978 Sep; 121(3):844-50. PubMed ID: 308523
[TBL] [Abstract][Full Text] [Related]
12. DNA changes in spinal cords of rats with experimental allergic encephalomyelitis.
Smith ME; Somera FP; Saldivar R; Massacesi L; Trotter J
J Neurochem; 1984 Dec; 43(6):1635-41. PubMed ID: 6208337
[TBL] [Abstract][Full Text] [Related]
13. Norepinephrine depletion in the spinal cord gray matter of rats with experimental allergic encephalomyelitis.
White SR; Bhatnagar RK; Bardo MT
J Neurochem; 1983 Jun; 40(6):1771-3. PubMed ID: 6602207
[TBL] [Abstract][Full Text] [Related]
14. Cell surface endothelial proteins altered in experimental allergic encephalomyelitis.
Sternberger NH; Sternberger LA; Kies MW; Shear CR
J Neuroimmunol; 1989 Feb; 21(2-3):241-8. PubMed ID: 2783587
[TBL] [Abstract][Full Text] [Related]
15. Serotonin immunoreactivity in spinal cord axons and terminals of rodents with experimental allergic encephalomyelitis.
White SR; Vyas D; Bieger D
Neuroscience; 1985 Nov; 16(3):701-9. PubMed ID: 3912676
[TBL] [Abstract][Full Text] [Related]
16. Relation between the increase in the diffusional permeability of the blood-central nervous system barrier and other changes during the development of experimental allergic encephalomyelitis in the Lewis rat.
Daniel PM; Lam DK; Pratt OE
J Neurol Sci; 1983; 60(3):367-76. PubMed ID: 6415240
[TBL] [Abstract][Full Text] [Related]
17. A spatial analysis of the blood-brain barrier damage in experimental allergic encephalomyelitis.
Juhler M; Blasberg RG; Fenstermacher JD; Patlak CS; Paulson OB
J Cereb Blood Flow Metab; 1985 Dec; 5(4):545-53. PubMed ID: 3877064
[TBL] [Abstract][Full Text] [Related]
18. Accelerated response to reinoculation in experimental allergic encephalomyelitis: histopathologic study.
Levine S; Saltzman A
J Neuropathol Exp Neurol; 1991 Mar; 50(2):126-33. PubMed ID: 1707089
[TBL] [Abstract][Full Text] [Related]
19. Glial fibrillary acidic protein in acute and chronic relapsing experimental allergic encephalomyelitis (EAE).
Smith ME; Somera FP; Swanson K; Eng LF
Prog Clin Biol Res; 1984; 146():139-44. PubMed ID: 6609373
[No Abstract] [Full Text] [Related]
20. Thymoquinone inhibits the activation of NF-kappaB in the brain and spinal cord of experimental autoimmune encephalomyelitis.
Mohamed A; Afridi DM; Garani O; Tucci M
Biomed Sci Instrum; 2005; 41():388-93. PubMed ID: 15850137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
